Estimates down on delayed margin recovery

Jm Ab (Buy, TP: SEK170.00) - Passing the trough

Q1 EBIT was 4% below our estimate and Infront consensus, while EPS fell well short in percentage terms due to a low nominal figure. KPIs did not recover as much as we expected, although JM reiterated its target to increase housing starts to 3,800 units p.a., citing macroeconomic conditions as a key factor. Given the current market outlook, we believe the company has passed the trough on EPS, as we expect starts and sales to recover in late 2025 and 2026. We reiterate our BUY and target price of ...

Margins continue to surprise negatively

Up to BUY - excessive share price fall

Important year coming up

Entering 2025 with a strong portfolio

Another cash flow-intensive year

Growing earnings in 2025

Favouring peers

Good value

Recovery in the making

Mixed upside potential, despite market recovery expectations

Pent-up demand and falling interest rates remain the backbone for newbuild recovery expectations. However, as the recovery has not yet started, property developers screen as the most attractive long-term, but visibility remains mixed. Diversified construction companies are more attractive on near-term P/Es, although many seem to be fully valued on solid share-price performance over the past six months. We maintain a neutral sector view; NCC and Skanska are our top picks.

Jm Ab (Buy, TP: SEK170.00) - BUY on the dip

JM’s share price has been volatile over the past three years, trading in waves on recovery expectations. As the Swedish residential market has yet to recover, expectations have recently fallen further, and the stock has reached old lows. However, we expect a market recovery in late-2025 and 2026, and we believe this has created an attractive entry point. KPIs (unit sales and unit starts) are our Q1 focus point, as profits are still affected by cycle lows and a trailing profit recognition. We hav...

Skanska (Buy, TP: SEK270.00) - Q1e risk, but SOTP upside potential

With only a minor SEK110m divestment in ‘Central’ in the quarter, we see downside risk to consensus for Q1. However, supported by a solid balance sheet and investments in Commercial Development (CD), Investment Properties (IP) and Residential Development (RD), we see solid upside potential from an SOTP perspective, and believe capital releases remain Skanska’s main potential share price catalyst. Due to FX, we have lowered our 2025–2027e EPS by c2% on average, and our target price to SEK270 (280...

Ncc (Buy, TP: SEK220.00) - Target price raised on project gains

Having started and sold another commercial development, with an expected 2027 delivery, we have raised our 2027e EPS by c8%. Given NCC’s project development planned for 2027–2028e, we believe the stock offers an attractive EPS growth profile. However, similar to peers, Q1 is likely to be a loss-making quarter due to Nordic winter effects. We reiterate our BUY and have raised our target price to SEK220 (200).

Peab (Hold, TP: SEK85.00) - Seasonal losses expected

Given Peab’s large Civil Engineering and Industry (including Asphalt) operations, it tends to report a loss in Q1. We are broadly in line with consensus for Q1e EPS and order intake, although we are below for 2025–2027e. We believe there is a better risk/reward in peers, and reiterate our HOLD and SEK85 target price.

Skanska AB: 1 director

A director at Skanska AB maiden bought 4,000 shares at 22.777USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

Selvaag Bolig (Sell, TP: NOK32.00) - Unit sales in line, EPS still tra...

Today’s Q1 trading update showed a unit sales recovery broadly in line with our forecast. However, while starts were above our forecast, our 2025e is unchanged at 700 units. Despite KPIs seemingly recovering as expected, we still see downside risk for the stock given the long lead time to profit and dividends and as the valuation looks high relative to peers. Ahead of the Q1 results (due at 07:00 CET on 21 May), we forecast marginally negative Q1 EPS on few deliveries. We reiterate our SELL and ...

Veidekke (Hold, TP: NOK160.00) - Seasonal low despite mild winter

Q1 is typically the low season for Veidekke on Nordic winter effects and a seasonal EBIT margin decline in the Infrastructure division (including asphalt). Despite the mild winter in the Nordics in Q1, we expect the positive impact to be limited as weather effects tend to affect Q4 more than Q1. We expect zero EPS for Q1. We reiterate our HOLD and NOK160 target price.

Sales as expected, deliveries above